NCT07139925

Brief Summary

The adaptation of the SC-COPDI for IPF patients

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
156

participants targeted

Target at P50-P75 for all trials

Timeline
8mo left

Started Jan 2025

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress67%
Jan 2025Jan 2027

Study Start

First participant enrolled

January 9, 2025

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

August 18, 2025

Completed
6 days until next milestone

First Posted

Study publicly available on registry

August 24, 2025

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2026

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2027

Expected
Last Updated

September 4, 2025

Status Verified

July 1, 2025

Enrollment Period

12 months

First QC Date

August 18, 2025

Last Update Submit

August 27, 2025

Conditions

IPF

Outcome Measures

Primary Outcomes (1)

  • Evaluation of a tool for assessing self-care in patients with IPF

    To make a tool available for assessing self-care in patients with IPF by adapting an instrument designed for patients with COPD to those with IPF

    baseline

Interventions

Self-care of COPD Inventory (SC-COPDI)OTHER

Self-care of COPD Inventory (SC-COPDI) - Assess the self-care of patients with IPF by adapting a tool designed for patients with COPD to those affected by IPF

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients diagnosed with idiopathic pulmonary fibrosis

You may qualify if:

  • Patients diagnosed with idiopathic pulmonary fibrosis (IPF)
  • Patients over 18 years of age
  • Patients who are able to provide informed consent to participate in the study

You may not qualify if:

  • Patients diagnosed with cognitive impairment
  • Patients who are unable to speak, read, or write in Italian
  • Patients who are blind or deaf

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Fondazione Policlinico Universitario Agostino Gemelli

Roma, Roma, 00168, Italy

Location

Study Officials

  • Luca Richeldi

    Fondazione Policlinico Universitario A. Gemelli, IRCCS

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
OTHER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

August 18, 2025

First Posted

August 24, 2025

Study Start

January 9, 2025

Primary Completion

January 1, 2026

Study Completion (Estimated)

January 1, 2027

Last Updated

September 4, 2025

Record last verified: 2025-07

Locations

IT(1)